Abstract:Viral infection activates the type I interferons (IFNs) and cellular antiviral responses. Eukaryotic initiation factor 4A-III (eIF4A3) has been shown to promote influenza A virus (IAV) replication by promoting viral mRNA splicing and spliced mRNA nuclear export. Here, we identified eIF4A3 as a negative regulator of virus-triggered type I IFN induction. Our study found that eIF4A3 promoted multiple RNA viruses' replication by binding to IFN regulatory factor 3 (IRF3) and impaired the interaction between tank-binding kinase 1 (TBK1) and IRF3, leading to attenuation of the phosphorylation of IRF3 by TBK1, the formation of IRF3 dimer, and the nuclear translocation of IRF3. This impaired its biological functions in the nucleus, which blocked IRF3 binding to interferon-stimulated response element (ISRE) and the interaction of IRF3 and CBP/p300, resulting in inhibiting the transcription of IFN-β and downstream IFN-stimulated genes (ISGs), thereby impairing innate antiviral immune responses against RNA viruses. These findings reveal a previously unknown function of eIF4A3 in host innate immunity and establish a mechanistic link between eIF4A3 and IRF3 activation that expands potential therapeutic strategies for viral infectious diseases. IMPORTANCE Production of type I IFN is pivotal for the cellular antiviral immunity. Virus infection leads to the activation of transcription factor IRF3 and subsequent production of type I IFN to eliminate viral infection. Thus, the regulation of IRF3 activity is an important way to affect type I IFN production. IRF3 activation requires phosphorylation, dimerization, and nuclear translocation. Here, we first reported that eIF4A3, a member of DEAD box family, served as a negative regulator of antiviral innate immune responses by inhibiting IRF3 activation. Mechanistically, eIF4A3 binds to IRF3 to impair the recruitment of IRF3 by TBK1, which is independent of eIF4A3 ATP binding, ATPase, and RNA helicase activities. Our study delineates a common mechanism of eIF4A3 promoting replication of different RNA viruses and provides important insights into the negative regulation of host antiviral innate immune responses against virus infections.

E3 Ligase HECTD3 Promotes RNA Virus Replication and Virus-Induced Inflammation Via K33-linked Polyubiquitination of PKR

Eif4a3 Promotes RNA Viruses' Replication by Inhibiting Innate Immune Responses.

Toll-like Receptor 3 Signaling Inhibits Double-Stranded RNA-induced Apoptosis of Macrophages (168.21)

PKACs Attenuate Innate Antiviral Response by Phosphorylating VISA and Priming It for MARCH5-mediated Degradation

E3 ligase Nedd4l promotes antiviral innate immunity by catalyzing K29-linked cysteine ubiquitination of TRAF3

E3 Ligase FBXW7 is Critical for RIG-I Stabilization During Antiviral Responses

RNA Viruses Promote Activation of the NLRP3 Inflammasome Through a RIP1-RIP3-DRP1 Signaling Pathway

Induction of protein kinase PKR-dependent activation of interferon regulatory factor 3 by vaccinia virus occurs through adapter IPS-1 signaling

E3 Ubiquitin Ligases: The Operators of the Ubiquitin Code That Regulates the RLR and cGAS-STING Pathways

HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection.

E3 Ubiquitin Ligase NEURL3 Promotes Innate Antiviral Response Through Catalyzing K63‐linked Ubiquitination of IRF7

The E3 Ubiquitin Ligase Triad3A Negatively Regulates the RIG-I/MAVS Signaling Pathway by Targeting TRAF3 for Degradation

The deubiquitinase BAP1 and E3 ligase UBE3C sequentially target IRF3 to activate and resolve the antiviral innate immune response

The ORF3 Protein of Genotype 1 Hepatitis E Virus Suppresses TLR3-induced NF-κB Signaling via TRADD and RIP1

RTN3 inhibits RIG-I-mediated antiviral responses by impairing TRIM25-mediated K63-linked polyubiquitination

ORF3 of Hepatitis E Virus Inhibits the Expression of Proinflammatory Cytokines and Chemotactic Factors in LPS-Stimulated Human PMA-THP1 Cells by Inhibiting NF-κB Pathway.

Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3

Protein Kinase PKR-Dependent Activation of Mitogen-Activated Protein Kinases Occurs Through Mitochondrial Adapter IPS-1 and is Antagonized by Vaccinia Virus E3L

Regulation of PKR and IRF-1 During Hepatitis C Virus RNA Replication

Hepatitis E Virus Infection Remodels the Mature Trnaome in Macrophages to Orchestrate NLRP3 Inflammasome Response.

The Orf3 Protein Of Genotype 1 Hepatitis E Virus Suppresses Tlr3-Induced Nf-Kappa B Signaling Via Tradd And Rip1